• 1. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 2. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 3. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 4. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 5. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives 21-hydroxysteroids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives Hydroxysteroids 21-hydroxysteroids

Comprehensive Overview of 17-Epihydrocortisone (CAS No. 116907-82-5): Properties, Applications, and Research Insights

17-Epihydrocortisone (CAS No. 116907-82-5) is a steroidal compound with significant biochemical and pharmacological relevance. As an epimer of hydrocortisone, it belongs to the corticosteroid family, which plays a critical role in anti-inflammatory and immunomodulatory processes. The compound's unique structural configuration at the C17 position distinguishes it from other corticosteroids, influencing its metabolic pathways and biological activity. Researchers and pharmaceutical developers are increasingly interested in 17-Epihydrocortisone derivatives due to their potential therapeutic applications, particularly in dermatology and endocrinology.

In recent years, the demand for steroid-based therapeutics has surged, driven by advancements in precision medicine and personalized treatment protocols. 17-Epihydrocortisone has garnered attention for its potential role in managing conditions like chronic inflammation, autoimmune disorders, and skin diseases. Its mechanism of action involves binding to glucocorticoid receptors, modulating gene expression, and suppressing pro-inflammatory cytokines. This aligns with current trends in targeted drug delivery and anti-aging research, where users frequently search for terms like "natural cortisol regulators" or "steroids for skin repair."

The synthesis and characterization of 116907-82-5 require specialized techniques, including high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy. Analytical studies highlight its stability under controlled conditions, making it a viable candidate for formulation development. Notably, 17-Epihydrocortisone exhibits lower mineralocorticoid activity compared to its analogs, reducing risks associated with fluid retention—a common concern among patients using corticosteroids. This property addresses frequent queries such as "steroid alternatives with fewer side effects" in online health forums.

Beyond clinical applications, 17-Epihydrocortisone is a subject of interest in cosmeceutical research. Its anti-inflammatory and collagen-stimulating effects make it a potential ingredient in anti-aging creams and wound-healing formulations. Consumer searches for "cortisone in skincare" or "steroids for eczema" reflect growing public curiosity about its non-prescription uses. However, regulatory guidelines emphasize rigorous safety assessments before commercial adoption.

Ongoing studies explore the compound's interactions with other biomolecules, such as cytochrome P450 enzymes, to optimize dosing regimens. Collaborative efforts between academia and industry aim to develop sustainable synthesis methods for CAS No. 116907-82-5, addressing environmental concerns linked to traditional steroid production. These initiatives resonate with global trends toward green chemistry and eco-friendly pharmaceuticals.

In summary, 17-Epihydrocortisone (CAS No. 116907-82-5) represents a multifaceted compound with expanding applications in medicine and biotechnology. Its evolving profile underscores the importance of continued research to unlock its full potential while addressing safety and sustainability challenges.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)